Cutler Group LLC / CA - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$18
-69.0%
200
-81.1%
0.00%
-75.0%
Q2 2023$58
+262.5%
1,060
+92.7%
0.01%
+300.0%
Q1 2023$16
-33.3%
550
-31.2%
0.00%0.0%
Q4 2022$24
-100.0%
800
-87.9%
0.00%
-33.3%
Q3 2022$54,000
-67.1%
6,600
+272.5%
0.00%
-72.7%
Q2 2022$164,000
-85.7%
1,772
-96.2%
0.01%
-82.0%
Q1 2022$1,149,000
+3606.5%
46,955
+3378.1%
0.06%
+6000.0%
Q3 2021$31,000
-22.5%
1,350
-77.5%
0.00%
-50.0%
Q1 2021$40,000
-68.8%
6,0000.0%0.00%
-66.7%
Q4 2020$128,000
+91.0%
6,000
+270.4%
0.01%
+50.0%
Q3 2020$67,000
+13.6%
1,620
-67.6%
0.00%0.0%
Q2 2020$59,000
-82.7%
5,000
-57.3%
0.00%
-77.8%
Q1 2020$341,000
-3.9%
11,700
-20.9%
0.02%
-18.2%
Q4 2019$355,000
+17650.0%
14,800
+393.3%
0.02%
Q3 2019$2,000
-97.4%
3,000
-84.6%
0.00%
-100.0%
Q2 2019$76,000
-84.2%
19,500
-61.9%
0.01%
-86.0%
Q1 2019$481,000
+117.6%
51,200
+72.4%
0.05%
+138.1%
Q4 2018$221,000
+176.2%
29,700
+120.0%
0.02%
+250.0%
Q3 2018$80,000
+17.6%
13,500
+193.5%
0.01%
+20.0%
Q2 2018$68,0004,6000.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders